Shares of Gilead Sciences Inc. fell sharply on Monday in line with the broad decline in the health-care sector, which is the worst performer in the S&P 500. The Securities and Exchange Commission also charged five Florida residents, including two lawyers with insider trading ahead of Gilead’s buy of Pharmasset Inc. in 2011. The health-care sector dropped 3.9% with almost all the stocks in the sector trading lower except Johnson & Johnson which is up 0.3%. Gilead shares were off 5% to $85.23, on track for fourth consecutive day of losses.
Source Article from http://stream.marketwatch.com/story/markets/SS-4-4/SS-4-86596/
